← Evidence map

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2021

Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD Severity.

Mona A Hegazy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34040409